Logo image
Timeliness in Public Health Emergency Response: An Epidemiological Assessment of a Statewide SARS-CoV-2 Testing Initiative (April 2020-July 2021)
Journal article   Peer reviewed

Timeliness in Public Health Emergency Response: An Epidemiological Assessment of a Statewide SARS-CoV-2 Testing Initiative (April 2020-July 2021)

Sophia Misterek, Martha Carvour, Elsy Barahona Portillo, Derrick Shostrom and Precious-Junia de-Winton Cummings
American journal of infection control
03/20/2026
DOI: 10.1016/j.ajic.2026.03.007
PMID: 41865769

View Online

Abstract

Timely diagnostic testing is essential for interrupting transmission and supporting infection prevention during public health emergencies. We conducted a retrospective secondary analysis of cross-sectional data from individuals tested between April 2020 and July 2021, within Test Iowa, a statewide diagnostic initiative. The primary outcome was the interval from symptom onset to testing, classified as early (≤4 days) or later (>4 days). Multivariable logistic regression identified predictors of later testing, and secondary analyses summarized intervals across the testing process. Among symptomatic testers, 36% were tested >4 days after symptom onset. Later testing was associated with age ≥50 years, known exposure (OR=1.31, 95% CI=1.28-1.33), and moderate (OR=1.13, 95% CI=1.11-1.16) or severe symptoms (OR=1.46, 95% CI=1.32-1.61). Early testing was more common among healthcare workers (OR=0.93, 95% CI=0.91-0.94) and individuals reporting systemic symptoms (OR=0.91, 95% CI=0.88-0.93). The longest delays occurred between scheduling initiation and testing, while laboratory intervals remained stable. Findings show that the most substantial barriers to timely diagnosis occurred before specimen collection rather than within laboratory operations. Improving scheduling pathways and access to testing sites may enhance diagnostic timeliness and strengthen infection control capacity in future emergencies.
COVID-19 response testing access preparedness health seeking delay diagnostic systems SARS-CoV-2 testing

Details

Metrics

1 Record Views
Logo image